ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Conversation with The Cancer Letter: Pat White: NIH Funding “Our Only Concern”

September 26, 2014

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 16, 1998

Resolutions Urge Doubling Of NIH Budget From ’98 Level.

March 9, 2001

Congress Ignores construction Fund Reprogramming

February 18, 1977

FDA says new tools needed to speed therapeutics development.

March 26, 2004

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

June 12, 1992